N-Me-Leu-OBzl · p-tosylate

N-Me-Leu-OBzl · p-tosylate is a chiral, leucine-derived amino acid derivative in which the nitrogen is N-methylated (N-Me) and the carboxyl functionality is present as a benzyl ester (OBzl), while the molecule is additionally converted into a p-tosylate salt/derivative that introduces a tosylate counterion and strong leaving-group character for subsequent transformations. The leucine backbone retains a stereogenic center at the alpha carbon, enabling stereochemically defined downstream coupling and derivatization. The benzyl ester and N-methylated amide-like environment modulate nucleophilicity and compatibility with peptide coupling conditions, whereas the tosylate-associated functionality supports controlled substitution chemistry. The combination of protected carboxyl as an ester, N-substitution, and tosylate reactivity makes the compound a practical chiral intermediate for amino acid ester synthesis, protected amino acid chemistry, and stepwise construction of N-methylated peptide fragments.

1. Peptide Synthesis

N-Me-Leu-OBzl · p-tosylate supports peptide building block preparation workflows where a defined N-methylated leucine residue is required for amide bond formation in peptidic scaffolds. The benzyl ester carboxyl protection is compatible with orthogonal deprotection strategies, allowing carboxyl activation after selective ester handling while maintaining the N-methyl substitution pattern that influences coupling reactivity and conformational preferences. The tosylate-associated leaving-group character can facilitate controlled formation of activated intermediates or substitution steps that precede peptide coupling. Downstream use can include assembly of N-methylated peptide segments for structure-activity relationship studies and peptidomimetic construction, leveraging stereochemical integrity at the alpha center.

2. Chiral Building Block Development

N-Me-Leu-OBzl · p-tosylate functions as a chiral amino acid intermediate for stereodefined synthetic organic chemistry, where retention of the leucine stereocenter is required for downstream fragment incorporation. The N-methylated nitrogen and benzyl ester create a protected amino acid ester framework that can be carried through multi-step sequences without exposing a free carboxylic acid or primary amine. The p-tosylate component enables substitution chemistry that can be used to access alternative protected derivatives or to generate coupling-ready forms under conditions compatible with chiral intermediates. The resulting stereochemically defined leucine-derived fragment can be employed in asymmetric synthesis planning, chiral library preparation, and iterative side-chain functionalization routes.

3. Side-Chain Functionalization

N-Me-Leu-OBzl · p-tosylate is suitable for side-chain modification strategies in amino acid derivatization, since the leucine skeleton provides a hydrophobic isobutyl side chain while the protected termini allow selective functional group transformations. The benzyl ester and N-methyl protection pattern reduce competing reactivity from carboxylate and amine functionalities, enabling chemoselective steps that target side-chain or intermediate-stage electrophiles. The tosylate-associated leaving-group character can be leveraged to introduce new substituents or to generate intermediates that undergo further nucleophilic capture. Downstream outcomes include preparation of leucine-based analogs for biochemical research intermediate generation, combinatorial synthesis, and peptidomimetic scaffold diversification where side-chain identity and terminal protection state must be controlled.

4. Protected Amino Acid Chemistry

N-Me-Leu-OBzl · p-tosylate aligns with protected amino acid synthesis workflows that require orthogonality between ester protection and subsequent conversion to coupling-ready carboxyl derivatives. The benzyl ester (OBzl) provides a handle for controlled deprotection and reactivation, while the N-methyl substitution defines the nitrogen substitution state used in N-methylated peptide bond patterns. The p-tosylate derivative introduces a functional group environment that can participate in activation or substitution steps, supporting stepwise construction of amino acid derivatives without premature formation of free acid or unprotected amine. Downstream use includes preparation of process-relevant intermediates for fine chemical synthesis and peptide building block preparation where protection strategy and stereochemical consistency are central.

5. Pharmaceutical Manufacturing

N-Me-Leu-OBzl · p-tosylate can be applied in pharmaceutical manufacturing contexts as a chiral intermediate for producing N-methylated amino acid fragments used in peptide-like active ingredient synthesis and related process chemistry. The protected benzyl ester and N-methylated nitrogen help manage chemoselectivity during manufacturing sequences, limiting side reactions that could occur with free carboxylic acids or primary amines. The tosylate-associated leaving-group character can support conversion steps that generate coupling-ready derivatives or downstream protected forms under controlled synthetic conditions. Resulting derivatives can feed into larger-scale peptide or peptidomimetic construction, enabling consistent stereochemical incorporation and reproducible intermediate handling in industrial fine chemical production.

6. Chemical Manufacturing Intermediates

N-Me-Leu-OBzl · p-tosylate serves as a chemical manufacturing intermediate for specialty chemical production where chiral amino acid ester derivatives are required for downstream derivatization and controlled functional group interconversion. The leucine-derived stereocenter, combined with benzyl ester protection, provides a stable platform for sequential transformations while maintaining a defined substitution pattern at nitrogen. The p-tosylate component supports leaving-group-driven steps that can be integrated into manufacturing route design for generating alternative protected amino acid derivatives or activated intermediates. Downstream utility includes preparation of N-methyl leucine-containing fragments for analytical standards, synthetic methodology development, and industrial-scale synthesis of amino acid-based building blocks used across peptide science and related applied product development.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. The spatiotemporal control of signalling and trafficking of the GLP-1R